Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

CDXC

CDXC Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of CDXC by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
CDXC Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
CDXC Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CDXC Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in CDXC holdings by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by CDXC's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for CDXC

Quiver Logo

No former government officials on record as having lobbied for CDXC

Revolving Door Dashboard

CDXC Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

CDXC Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
CDXC Income Statement
CDXC Balance Sheet
CDXC Cash Flow
U.S. Patents

New CDXC patent grants

  • Patent Title: Methods of preparing reduced nicotinamide riboside and derivatives thereof Oct. 13, 2026
  • Patent Title: Nicotinamide riboside and derivatives thereof in intravenous formulations and methods of use thereof Feb. 24, 2026
  • Patent Title: Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations Dec. 02, 2025
  • Patent Title: Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development Oct. 07, 2025
  • Patent Title: Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development Dec. 13, 2022
  • Patent Title: Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof Mar. 15, 2022
  • Patent Title: Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof Feb. 08, 2022
  • Patent Title: Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof Jan. 04, 2022
  • Patent Title: Nicotinamide riboside compositions for topical use in treating skin conditions Jun. 15, 2021
  • Patent Title: B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof Mar. 02, 2021
  • Patent Title: Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development Dec. 08, 2020
  • Patent Title: Nicotinamide riboside compositions for topical use in treating skin conditions Jun. 23, 2020
  • Patent Title: Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions May. 07, 2019
  • Patent Title: Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as nad+ increasing precursors Jan. 22, 2019
  • Patent Title: Method for treating non-melanoma skin cancer by inducing udp-glucuronosyltransferase activity using pterostilbene Aug. 07, 2018
  • Patent Title: B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof Jun. 19, 2018
  • Patent Title: Method for inducing udp-glucuronosyltransferase activity using pterostilbene Sep. 23, 2014
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to CDXC from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
CDXC News

Recent insights relating to CDXC

CNBC Recommendations

Recent picks made for CDXC stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CDXC

CDXC Analyst Ratings

CDXC Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
CDXC Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $CDXC stock a Buy, Sell, or Hold?

  • What is the price target for $CDXC stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

CDXC Top Shareholders
Shareholder
Shares Held
CDXC Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $CDXC stock?

  • Who owns the most shares of $CDXC stock?

  • What funds own $CDXC stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CDXC Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CDXC Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About CDXC

No description available

CDXC (CDXC) Historical Stock Prices

CDXC (CDXC) closed at $7.87 on March 18, 2025. Over the past year its adjusted close ranged from $2.44 to $8.55. Daily prices go back to January 2, 2014, 2,810 trading days in all.

  • 1 month+34.07%
  • 3 months+31.17%
  • Year to date+48.35%
  • 1 year+163.21%
  • 3 years+201.53%
  • 5 years+170.45%
  • Max+458.16%
See every congressional and insider trade on the CDXC price chart

Quiver Premium charts CDXC's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Mar 18, 2025 7.91 7.92 7.75 7.87 7.87 554,833
Mar 17, 2025 7.83 8.00 7.68 7.94 7.94 682,305
Mar 14, 2025 7.76 7.90 7.58 7.84 7.84 689,237
Mar 13, 2025 7.70 7.78 7.32 7.72 7.72 615,556
Mar 12, 2025 7.87 8.00 7.81 7.83 7.83 987,502
Mar 11, 2025 7.88 8.19 7.63 7.90 7.90 1,348,594
Mar 10, 2025 7.80 8.05 7.58 7.88 7.88 1,151,582
Mar 7, 2025 7.70 8.00 7.35 7.70 7.70 1,083,631
Mar 6, 2025 8.39 8.50 7.55 7.69 7.69 2,348,304
Mar 5, 2025 6.71 9.18 6.67 8.55 8.55 18,709,491
Mar 4, 2025 5.54 5.71 5.26 5.60 5.60 1,136,583
Mar 3, 2025 5.65 5.92 5.46 5.50 5.50 669,357
Feb 28, 2025 5.43 5.68 5.43 5.64 5.64 429,015
Feb 27, 2025 5.66 5.70 5.43 5.44 5.44 404,884
Feb 26, 2025 5.50 5.79 5.44 5.66 5.66 351,121
Feb 25, 2025 5.49 5.52 5.34 5.44 5.44 326,598
Feb 24, 2025 5.43 5.54 5.25 5.50 5.50 475,185
Feb 21, 2025 5.78 5.80 5.41 5.42 5.42 451,926
Feb 20, 2025 5.86 5.86 5.55 5.70 5.70 393,957
Feb 19, 2025 5.94 5.94 5.67 5.84 5.84 714,622
Feb 18, 2025 5.97 6.06 5.79 5.91 5.91 526,012
Feb 14, 2025 5.65 5.96 5.62 5.87 5.87 543,604
Feb 13, 2025 5.52 5.62 5.43 5.58 5.58 297,817
Feb 12, 2025 5.44 5.55 5.38 5.48 5.48 305,819
Feb 11, 2025 5.51 5.56 5.48 5.50 5.50 249,140
Feb 10, 2025 5.55 5.62 5.46 5.60 5.60 309,085
Feb 7, 2025 5.66 5.70 5.50 5.52 5.52 234,032
Feb 6, 2025 5.69 5.77 5.63 5.69 5.69 286,581
Feb 5, 2025 5.54 5.80 5.51 5.69 5.69 261,181
Feb 4, 2025 5.48 5.59 5.45 5.50 5.50 266,572
Feb 3, 2025 5.50 5.67 5.45 5.49 5.49 342,109
Jan 31, 2025 5.88 5.96 5.62 5.63 5.63 330,788
Jan 30, 2025 5.95 6.05 5.72 5.88 5.88 250,603
Jan 29, 2025 5.89 6.08 5.81 5.90 5.90 233,804
Jan 28, 2025 5.80 5.87 5.65 5.85 5.85 212,856
Jan 27, 2025 5.87 5.96 5.60 5.81 5.81 344,546
Jan 24, 2025 5.94 6.09 5.87 5.95 5.95 210,200
Jan 23, 2025 5.85 6.03 5.78 5.98 5.98 325,563
Jan 22, 2025 6.12 6.13 5.79 5.92 5.92 348,887
Jan 21, 2025 6.06 6.25 6.01 6.09 6.09 408,762
Jan 17, 2025 5.69 6.03 5.65 5.94 5.94 364,986
Jan 16, 2025 5.82 5.82 5.56 5.65 5.65 414,923
Jan 15, 2025 5.55 5.79 5.47 5.77 5.77 462,300
Jan 14, 2025 5.34 5.44 5.24 5.43 5.43 323,964
Jan 13, 2025 5.23 5.52 5.17 5.26 5.26 554,355
Jan 10, 2025 5.39 5.43 5.25 5.27 5.27 303,501
Jan 8, 2025 5.32 5.48 5.28 5.45 5.45 241,319
Jan 7, 2025 5.38 5.41 5.16 5.40 5.40 387,971
Jan 6, 2025 5.60 5.64 5.33 5.38 5.38 428,547
Jan 3, 2025 5.47 5.68 5.44 5.51 5.51 332,665
Jan 2, 2025 5.41 5.53 5.30 5.48 5.48 466,175
Dec 31, 2024 5.46 5.55 5.26 5.30 5.30 256,736
Dec 30, 2024 5.45 5.55 5.34 5.45 5.45 410,484
Dec 27, 2024 5.55 5.64 5.44 5.52 5.52 284,958
Dec 26, 2024 5.40 5.76 5.38 5.61 5.61 416,395
Dec 24, 2024 5.31 5.46 5.21 5.44 5.44 196,968
Dec 23, 2024 5.46 5.51 5.25 5.30 5.30 512,330
Dec 20, 2024 5.31 5.55 5.25 5.49 5.49 1,204,945
Dec 19, 2024 5.76 5.85 5.40 5.41 5.41 955,911
Dec 18, 2024 6.00 6.05 5.62 5.70 5.70 651,444
Dec 17, 2024 6.14 6.14 5.87 6.00 6.00 662,351
Dec 16, 2024 6.10 6.23 6.04 6.15 6.15 642,411
Dec 13, 2024 6.30 6.40 6.10 6.12 6.12 685,742
Dec 12, 2024 6.40 6.64 6.34 6.38 6.38 493,038
Dec 11, 2024 6.76 6.81 6.45 6.45 6.45 525,733
Dec 10, 2024 6.59 6.82 6.56 6.71 6.71 531,475
Dec 9, 2024 6.68 7.00 6.54 6.60 6.60 586,091
Dec 6, 2024 7.05 7.05 6.60 6.72 6.72 631,904
Dec 5, 2024 7.45 7.49 6.62 6.66 6.66 1,394,752
Dec 4, 2024 7.58 7.79 7.46 7.53 7.53 570,177
Dec 3, 2024 7.44 7.73 7.41 7.61 7.61 608,463
Dec 2, 2024 7.76 7.83 7.55 7.56 7.56 718,570
Nov 29, 2024 7.60 7.97 7.60 7.72 7.72 483,252
Nov 27, 2024 7.62 7.89 7.41 7.64 7.64 667,962
Nov 26, 2024 7.30 7.75 7.15 7.59 7.59 1,030,386
Nov 25, 2024 7.50 7.51 7.30 7.46 7.46 871,601
Nov 22, 2024 7.50 7.52 7.09 7.44 7.44 1,103,666
Nov 21, 2024 7.56 7.85 7.37 7.63 7.63 1,010,291
Nov 20, 2024 7.52 7.61 7.26 7.50 7.50 578,532
Nov 19, 2024 7.23 7.67 7.09 7.52 7.52 1,163,738
Nov 18, 2024 6.96 7.39 6.85 7.27 7.27 1,436,178
Nov 15, 2024 7.03 7.13 6.80 6.82 6.82 1,037,216
Nov 14, 2024 7.04 7.42 6.82 7.20 7.20 834,561
Nov 13, 2024 7.35 7.54 6.97 7.01 7.01 1,267,256
Nov 12, 2024 7.03 7.58 7.02 7.25 7.25 2,144,286
Nov 11, 2024 6.49 7.02 6.22 7.01 7.01 1,268,279
Nov 8, 2024 6.68 6.79 6.38 6.50 6.50 979,303
Nov 7, 2024 6.98 7.03 6.71 6.77 6.77 993,667
Nov 6, 2024 6.44 7.08 6.13 6.99 6.99 1,909,163
Nov 5, 2024 5.71 6.38 5.54 6.11 6.11 2,132,130
Nov 4, 2024 5.72 6.18 5.36 5.74 5.74 3,911,912
Nov 1, 2024 4.12 5.98 3.83 5.86 5.86 37,879,777
Oct 31, 2024 3.57 3.62 3.49 3.49 3.49 638,203
Oct 30, 2024 3.64 3.68 3.49 3.58 3.58 319,165
Oct 29, 2024 3.67 3.67 3.55 3.62 3.62 98,540
Oct 28, 2024 3.51 3.74 3.51 3.67 3.67 249,288
Oct 25, 2024 3.45 3.59 3.45 3.47 3.47 206,838
Oct 24, 2024 3.47 3.53 3.42 3.43 3.43 201,007
Oct 23, 2024 3.46 3.47 3.39 3.46 3.46 183,078
Oct 22, 2024 3.48 3.54 3.42 3.49 3.49 161,373
Oct 21, 2024 3.50 3.50 3.42 3.46 3.46 119,003
Oct 18, 2024 3.43 3.53 3.41 3.50 3.50 161,552
Oct 17, 2024 3.56 3.56 3.42 3.44 3.44 195,491
Oct 16, 2024 3.36 3.58 3.28 3.56 3.56 392,568
Oct 15, 2024 3.39 3.43 3.28 3.35 3.35 552,914
Oct 14, 2024 3.54 3.62 3.41 3.41 3.41 243,522
Oct 11, 2024 3.44 3.57 3.43 3.55 3.55 228,883
Oct 10, 2024 3.25 3.47 3.18 3.44 3.44 334,097
Oct 9, 2024 3.25 3.37 3.18 3.25 3.25 284,303
Oct 8, 2024 3.29 3.31 3.23 3.27 3.27 244,833
Oct 7, 2024 3.39 3.39 3.26 3.32 3.32 301,830
Oct 4, 2024 3.51 3.54 3.38 3.38 3.38 167,904
Oct 3, 2024 3.43 3.62 3.42 3.47 3.47 196,037
Oct 2, 2024 3.51 3.53 3.42 3.47 3.47 202,600
Oct 1, 2024 3.66 3.66 3.50 3.56 3.56 233,941
Sep 30, 2024 3.74 3.80 3.62 3.65 3.65 343,812
Sep 27, 2024 3.85 3.89 3.73 3.80 3.80 174,238
Sep 26, 2024 3.85 3.87 3.73 3.78 3.78 242,861
Sep 25, 2024 3.79 3.87 3.72 3.78 3.78 170,948
Sep 24, 2024 3.76 3.80 3.63 3.78 3.78 282,396
Sep 23, 2024 3.64 3.86 3.51 3.74 3.74 337,236
Sep 20, 2024 3.72 3.79 3.47 3.63 3.63 634,593
Sep 19, 2024 3.67 3.74 3.60 3.70 3.70 285,870
Sep 18, 2024 3.44 3.65 3.30 3.55 3.55 348,480
Sep 17, 2024 3.47 3.54 3.33 3.41 3.41 406,776
Sep 16, 2024 3.55 3.62 3.41 3.42 3.42 196,873
Sep 13, 2024 3.50 3.66 3.50 3.55 3.55 251,893
Sep 12, 2024 3.36 3.54 3.33 3.50 3.50 130,962
Sep 11, 2024 3.23 3.36 3.16 3.32 3.32 374,579
Sep 10, 2024 3.38 3.48 3.27 3.31 3.31 224,336
Sep 9, 2024 3.36 3.46 3.32 3.37 3.37 254,549
Sep 6, 2024 3.26 3.35 3.13 3.33 3.33 249,120
Sep 5, 2024 3.18 3.30 3.13 3.26 3.26 158,028
Sep 4, 2024 3.25 3.32 3.10 3.18 3.18 228,216
Sep 3, 2024 3.47 3.47 3.27 3.28 3.28 148,392
Aug 30, 2024 3.36 3.47 3.32 3.45 3.45 199,677
Aug 29, 2024 3.40 3.47 3.33 3.36 3.36 234,804
Aug 28, 2024 3.49 3.50 3.27 3.37 3.37 254,660
Aug 27, 2024 3.50 3.56 3.41 3.49 3.49 164,804
Aug 26, 2024 3.52 3.65 3.48 3.50 3.50 546,298
Aug 23, 2024 3.31 3.67 3.31 3.51 3.51 450,811
Aug 22, 2024 3.44 3.48 3.26 3.29 3.29 225,577
Aug 21, 2024 3.39 3.52 3.34 3.44 3.44 187,434
Aug 20, 2024 3.25 3.39 3.25 3.34 3.34 202,302
Aug 19, 2024 3.35 3.36 3.26 3.27 3.27 325,317
Aug 16, 2024 3.31 3.35 3.15 3.34 3.34 309,204
Aug 15, 2024 3.05 3.33 3.02 3.29 3.29 415,463
Aug 14, 2024 3.02 3.04 2.94 3.02 3.02 115,596
Aug 13, 2024 2.84 3.08 2.81 3.04 3.04 290,002
Aug 12, 2024 2.78 2.85 2.70 2.81 2.81 259,121
Aug 9, 2024 2.95 2.95 2.69 2.75 2.75 290,010
Aug 8, 2024 2.95 2.97 2.63 2.88 2.88 305,773
Aug 7, 2024 2.90 2.92 2.62 2.63 2.63 189,536
Aug 6, 2024 2.69 2.87 2.68 2.82 2.82 176,060
Aug 5, 2024 2.58 2.70 2.53 2.69 2.69 296,499
Aug 2, 2024 2.71 2.77 2.54 2.77 2.77 288,798
Aug 1, 2024 2.99 3.02 2.70 2.74 2.74 330,925
Jul 31, 2024 3.04 3.04 2.95 2.99 2.99 167,551
Jul 30, 2024 2.90 3.02 2.83 2.99 2.99 197,250
Jul 29, 2024 3.07 3.16 2.89 2.91 2.91 282,148
Jul 26, 2024 3.19 3.28 3.04 3.07 3.07 271,015
Jul 25, 2024 3.22 3.35 3.08 3.19 3.19 377,334
Jul 24, 2024 3.05 3.35 2.96 3.20 3.20 391,854
Jul 23, 2024 2.98 3.11 2.94 3.07 3.07 235,211
Jul 22, 2024 2.81 2.99 2.78 2.97 2.97 175,802
Jul 19, 2024 2.79 2.84 2.74 2.77 2.77 167,019
Jul 18, 2024 2.90 2.96 2.74 2.76 2.76 282,553
Jul 17, 2024 3.02 3.02 2.85 2.91 2.91 346,332
Jul 16, 2024 2.79 3.10 2.79 3.07 3.07 515,088
Jul 15, 2024 2.74 2.87 2.68 2.77 2.77 359,413
Jul 12, 2024 2.90 3.08 2.52 2.61 2.61 708,914
Jul 11, 2024 2.65 2.92 2.65 2.88 2.88 331,566
Jul 10, 2024 2.60 2.67 2.56 2.63 2.63 146,594
Jul 9, 2024 2.54 2.66 2.48 2.63 2.63 371,304
Jul 8, 2024 2.57 2.62 2.40 2.51 2.51 360,275
Jul 5, 2024 2.49 2.55 2.44 2.51 2.51 253,679
Jul 3, 2024 2.57 2.62 2.50 2.54 2.54 133,145
Jul 2, 2024 2.68 2.71 2.55 2.58 2.58 234,013
Jul 1, 2024 2.77 2.79 2.61 2.69 2.69 387,694
Jun 28, 2024 2.64 2.80 2.57 2.73 2.73 6,312,544
Jun 27, 2024 2.64 2.85 2.52 2.65 2.65 472,372
Jun 26, 2024 2.43 2.69 2.31 2.67 2.67 398,054
Jun 25, 2024 2.50 2.68 2.42 2.44 2.44 427,137
Jun 24, 2024 2.75 2.87 2.55 2.55 2.55 328,374
Jun 21, 2024 2.70 2.77 2.67 2.73 2.73 277,067
Jun 20, 2024 2.80 2.89 2.71 2.71 2.71 236,821
Jun 18, 2024 2.93 3.03 2.73 2.75 2.75 367,660
Jun 17, 2024 2.96 3.02 2.85 2.96 2.96 238,991
Jun 14, 2024 3.16 3.23 2.96 2.98 2.98 230,230
Jun 13, 2024 3.16 3.34 3.13 3.20 3.20 349,894
Jun 12, 2024 3.11 3.19 2.98 3.03 3.03 209,099
Jun 11, 2024 3.08 3.20 3.00 3.08 3.08 301,329
Jun 10, 2024 3.32 3.32 3.03 3.08 3.08 392,386
Jun 7, 2024 3.10 3.49 3.09 3.20 3.20 1,227,837
Jun 6, 2024 2.90 2.95 2.81 2.86 2.86 147,698
Jun 5, 2024 2.78 2.91 2.77 2.86 2.86 209,857
Jun 4, 2024 2.94 2.97 2.66 2.79 2.79 303,480
Jun 3, 2024 2.76 3.08 2.75 2.93 2.93 376,727
May 31, 2024 2.82 2.88 2.76 2.76 2.76 162,019
May 30, 2024 2.91 2.93 2.75 2.83 2.83 174,025
May 29, 2024 2.70 2.89 2.70 2.87 2.87 182,075
May 28, 2024 3.11 3.12 2.71 2.77 2.77 475,324
May 24, 2024 3.24 3.35 3.06 3.12 3.12 198,351
May 23, 2024 3.19 3.32 3.15 3.25 3.25 136,137
May 22, 2024 3.15 3.21 3.01 3.17 3.17 216,067
May 21, 2024 3.13 3.23 3.07 3.16 3.16 160,917
May 20, 2024 3.29 3.39 2.85 3.16 3.16 368,691
May 17, 2024 3.50 3.54 3.25 3.30 3.30 258,676
May 16, 2024 3.62 3.68 3.45 3.48 3.48 195,391
May 15, 2024 3.65 3.80 3.61 3.63 3.63 173,914
May 14, 2024 3.39 3.66 3.39 3.66 3.66 217,329
May 13, 2024 3.41 3.50 3.33 3.38 3.38 170,679
May 10, 2024 3.39 3.63 3.38 3.42 3.42 222,238
May 9, 2024 3.61 3.82 3.40 3.52 3.52 315,059
May 8, 2024 3.75 3.85 3.71 3.83 3.83 130,102
May 7, 2024 3.85 3.89 3.63 3.75 3.75 213,213
May 6, 2024 3.77 3.98 3.74 3.80 3.80 240,609
May 3, 2024 3.80 3.92 3.71 3.78 3.78 122,188
May 2, 2024 3.69 3.85 3.62 3.76 3.76 154,737
May 1, 2024 3.53 3.68 3.42 3.66 3.66 140,869
Apr 30, 2024 3.53 3.64 3.46 3.54 3.54 145,684
Apr 29, 2024 3.44 3.62 3.40 3.56 3.56 159,589
Apr 26, 2024 3.38 3.52 3.38 3.44 3.44 180,257
Apr 25, 2024 3.44 3.51 3.36 3.39 3.39 193,155
Apr 24, 2024 3.47 3.65 3.37 3.40 3.40 179,658
Apr 23, 2024 2.95 3.44 2.94 3.40 3.40 461,357
Apr 22, 2024 3.41 3.72 2.89 2.95 2.95 878,373
Apr 19, 2024 3.78 3.90 3.61 3.69 3.69 309,514
Apr 18, 2024 3.99 4.01 3.77 3.79 3.79 199,416
Apr 17, 2024 4.00 4.18 3.92 3.97 3.97 296,676
Apr 16, 2024 3.87 4.06 3.82 3.94 3.94 250,565
Apr 15, 2024 3.83 3.98 3.75 3.93 3.93 232,922
Apr 12, 2024 4.02 4.19 3.62 3.85 3.85 438,863
Apr 11, 2024 3.99 4.09 3.81 4.09 4.09 270,817
Apr 10, 2024 3.99 4.04 3.71 3.92 3.92 287,306
Apr 9, 2024 4.29 4.31 3.91 3.98 3.98 451,805
Apr 8, 2024 4.06 4.37 4.06 4.21 4.21 302,834
Apr 5, 2024 4.33 4.65 3.88 4.02 4.02 689,031
Apr 4, 2024 3.95 4.47 3.86 4.32 4.32 917,478
Apr 3, 2024 3.70 3.95 3.61 3.95 3.95 349,804
Apr 2, 2024 3.66 3.90 3.56 3.59 3.59 365,549
Apr 1, 2024 3.46 3.63 3.22 3.61 3.61 345,208
Mar 28, 2024 3.61 3.77 3.17 3.48 3.48 489,656
Mar 27, 2024 3.87 3.95 3.55 3.67 3.67 434,070
Mar 26, 2024 3.81 4.04 3.42 3.84 3.84 628,614
Mar 25, 2024 3.61 4.06 3.57 3.79 3.79 894,476
Mar 22, 2024 3.23 3.59 3.04 3.56 3.56 620,436
Mar 21, 2024 2.99 3.24 2.95 3.20 3.20 519,492
Mar 20, 2024 2.65 3.07 2.35 3.06 3.06 1,233,671
Mar 19, 2024 3.17 3.20 2.60 2.71 2.71 1,029,510
Mar 18, 2024 2.45 3.58 2.45 2.99 2.99 2,302,407

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
CDXC Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at CDXC, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation